98%
921
2 minutes
20
The field of vascularized composite allograft (VCA) transplantation has seen steady, rapid growth, with new innovations driving the evolution from experimental procedures to more standardized therapies. With this expansion comes challenges with graft allocation, preservation, and postoperative graft rejection. Here, we outline the first example of subzero nonfreezing (SZNF), supercooled storage of a whole rat hindlimb with orthotopic transplantation. Rat hindlimbs were procured, loaded, and supercooled for 48 hours at -4°C (n = 4), after which, they were recovered. The loading and recovery phase were performed using subnormothermic machine perfusion (SNMP) during which viability markers (glucose and oxygen consumption, lactate, and resistance) were tracked. Control limbs underwent static cold storage (SCS). After ex vivo validation, the model was piloted in a transplant model, comparing 48 hours of SZNF (n = 1), 48 hours of SCS (n = 1), and 72 hours of SCS (n = 1), which demonstrated no survival beyond postoperative day 4 in the SCS models, and survival until the end of study (postoperative day [POD] 28) in the SZNF model. This study demonstrates the promise of this model in future studies on long-term VCA preservation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625614 | PMC |
http://dx.doi.org/10.1016/j.transproceed.2024.10.006 | DOI Listing |
Yonsei Med J
September 2025
The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.
Purpose: Ex vivo machine perfusion (EVMP) is increasingly recognized as a promising technique for enhancing the preservation and viability of donor organs, particularly in donation after circulatory death (DCD) liver transplantation (LT). This study validates a transplant surgeon-innovated EVMP protocol by assessing its efficacy in preserving liver function and reducing ischemia-reperfusion injury (IRI) in a porcine DCD-simulated liver transplant (DCD sLT) model.
Materials And Methods: Twenty Yorkshire pigs were used to compare static cold storage (SCS) and EVMP.
Am J Transplant
August 2025
Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville TN 37232 USA.
This study compares a novel static cold storage (SCS) method using 10°C preservation to conventional ice following thoracoabdominal normothermic regional perfusion (TA-NRP) in donation after circulatory death (DCD) heart transplantation. We retrospectively analyzed adult recipients at a single center from October 2020 to October 2024, excluding congenital and multi-organ transplants. A total of 147 recipients met inclusion criteria (Ice = 96; 10°C = 51).
View Article and Find Full Text PDFbioRxiv
July 2025
Elephas Biosciences, Madison, WI.
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, providing durable and even curative responses. However, most patients do not respond and current biomarkers (eg, programmed death ligand (PD-L1), mismatch repair deficiency (dMMR)/high microsatellite instability (MSI) and tumor mutational burden) lack predictive accuracy. Ex vivo profiling of patient-derived tumor fragments shows promise as a predictive biomarker but relies on substantial surgical tissue to mitigate intra-specimen heterogeneity.
View Article and Find Full Text PDFReg Anesth Pain Med
July 2025
Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Objective: Spinal cord stimulation (SCS) is a treatment option for chronic neuropathic pain conditions when conventional therapies have failed. However, objective and measurable long-term data on the effects of SCS are lacking. This study evaluates changes in objectively recorded mobility and the correlation with patient-reported outcomes in SCS-treated patients with intractable back and/or leg pain following lumbar spine surgery.
View Article and Find Full Text PDFPain Pract
July 2025
Rockefeller Neuroscience Institute, West Virginia University, Morgantown, West Virginia, USA.
Background: Spinal cord stimulation (SCS) is a nonpharmacological, minimally invasive intervention designed to ameliorate chronic low back pain. However, meta-analyses have not supported the use of SCS due to a lack of high-quality evidence. This work provides the necessary information to design better statistically powered clinical trials for SCS by providing estimates and variances for various patient-reported outcomes and biometrics across time in this population.
View Article and Find Full Text PDF